KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Pacific Biosciences Of California (PACB) over the last 14 years, with Q3 2025 value amounting to $1.7 million.

  • Pacific Biosciences Of California's Interest Expenses fell 5084.79% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 4396.88%. This contributed to the annual value of $13.4 million for FY2024, which is 649.1% down from last year.
  • Pacific Biosciences Of California's Interest Expenses amounted to $1.7 million in Q3 2025, which was down 5084.79% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Interest Expenses registered a high of $3.7 million during Q1 2022, and its lowest value of $1.7 million during Q1 2025.
  • Moreover, its 5-year median value for Interest Expenses was $3.6 million (2023), whereas its average is $3.2 million.
  • Per our database at Business Quant, Pacific Biosciences Of California's Interest Expenses soared by 57003.75% in 2021 and then tumbled by 5141.26% in 2025.
  • Pacific Biosciences Of California's Interest Expenses (Quarter) stood at $3.5 million in 2021, then increased by 4.86% to $3.6 million in 2022, then dropped by 2.11% to $3.6 million in 2023, then dropped by 22.79% to $2.8 million in 2024, then crashed by 36.92% to $1.7 million in 2025.
  • Its Interest Expenses stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.